code = """import json
import pandas as pd
import re

# Load data
with open(locals()['var_function-call-4813916406073336699'], 'r') as f:
    clinical_data = json.load(f)

with open(locals()['var_function-call-8760586505566200375'], 'r') as f:
    mutation_data = json.load(f)

# Convert to DataFrame
df_clinical = pd.DataFrame(clinical_data)
df_mutation = pd.DataFrame(mutation_data)

# Extract Barcode and Cancer Type
def parse_description(desc):
    match = re.search(r'(TCGA-[A-Z0-9]{2}-[A-Z0-9]{4})', desc)
    barcode = match.group(1) if match else None
    
    cancer_type = None
    if "Bladder urothelial carcinoma" in desc:
        cancer_type = "Bladder urothelial carcinoma"
    elif "Breast invasive carcinoma" in desc:
        cancer_type = "Breast invasive carcinoma"
    
    return barcode, cancer_type

df_clinical[['Barcode', 'CancerType']] = df_clinical['Patient_description'].apply(
    lambda x: pd.Series(parse_description(x))
)

# Check counts
count_bladder = df_clinical[df_clinical['CancerType'] == "Bladder urothelial carcinoma"].shape[0]
count_breast = df_clinical[df_clinical['CancerType'] == "Breast invasive carcinoma"].shape[0]

# Decision: Use Breast invasive carcinoma
# Reason: CDH1 is a marker for Breast (Lobular), and Bladder has few Female samples relative to Breast.
target_cancer = "Breast invasive carcinoma"

df_target = df_clinical[df_clinical['CancerType'] == target_cancer].copy()

# Filter Mutation Data
# Only CDH1 and PASS are already filtered in the query result
mutated_barcodes = set(df_mutation['ParticipantBarcode'].unique())

# Map mutation status
# Ensure barcodes match format. The clinical barcodes are TCGA-XX-XXXX.
# The mutation barcodes are also TCGA-XX-XXXX... (sometimes longer).
# We match the first 12 chars.
mutated_barcodes_short = set([x[:12] for x in mutated_barcodes])

df_target['has_CDH1'] = df_target['Barcode'].apply(lambda x: x in mutated_barcodes_short)

# Filter Histological Types
df_target = df_target[df_target['histological_type'].notna()]
df_target = df_target[df_target['histological_type'] != 'None']
df_target = df_target[df_target['histological_type'] != '[Not Applicable]'] # Just in case

# Marginal Totals (Row totals)
hist_counts = df_target['histological_type'].value_counts()
valid_hist_types = hist_counts[hist_counts > 10].index.tolist()

df_final = df_target[df_target['histological_type'].isin(valid_hist_types)]

# Contingency Table
# Rows: Histological Type, Cols: has_CDH1 (True/False)
contingency = pd.crosstab(df_final['histological_type'], df_final['has_CDH1'])

# Chi-Square Calculation
#          Mutated  Wildtype   Total
# Type1      O11      O12       R1
# Type2      O21      O22       R2
# ...
# Total      C1       C2        N

# Ensure we have both columns (True/False). If no mutations, we can't calc.
if True not in contingency.columns:
    contingency[True] = 0
if False not in contingency.columns:
    contingency[False] = 0

observed = contingency.values
row_totals = observed.sum(axis=1)
col_totals = observed.sum(axis=0)
grand_total = observed.sum()

chi2 = 0
for i in range(len(row_totals)):
    for j in range(len(col_totals)):
        expected = (row_totals[i] * col_totals[j]) / grand_total
        if expected > 0:
            chi2 += ((observed[i][j] - expected) ** 2) / expected

print("__RESULT__:")
print(json.dumps({
    "chi2_statistic": chi2,
    "target_cancer": target_cancer,
    "female_breast_count": count_breast,
    "female_bladder_count": count_bladder,
    "contingency_table": contingency.to_dict() # dict of dicts
}))"""

env_args = {'var_function-call-5764065623426829620': ['clinical_info'], 'var_function-call-5089065812566164436': [{'Patient_description': 'In the Ovarian serous cystadenocarcinoma dataset, patient TCGA-31-1953 (UUID 61feee94-3ac9-42fe-aaa3-dc6a3efe563c) is recorded as a FEMALE with vital status: Alive.', 'days_to_birth': '-19064.0', 'days_to_death': '[Not Applicable]', 'days_to_last_followup': '204.0', 'days_to_initial_pathologic_diagnosis': '0.0', 'age_at_initial_pathologic_diagnosis': '52.0', 'icd_10': 'C56.9', 'tissue_retrospective_collection_indicator': 'None', 'icd_o_3_histology': '8441/3', 'tissue_prospective_collection_indicator': 'None', 'history_of_neoadjuvant_treatment': 'No', 'icd_o_3_site': 'C56.9', 'tumor_tissue_site': 'Ovary', 'new_tumor_event_after_initial_treatment': 'None', 'radiation_therapy': 'NO', 'race': 'ASIAN', 'prior_dx': 'None', 'ethnicity': 'NOT HISPANIC OR LATINO', 'informed_consent_verified': 'YES', 'person_neoplasm_cancer_status': 'WITH TUMOR', 'patient_id': '1953', 'year_of_initial_pathologic_diagnosis': '2008.0', 'histological_type': 'Serous Cystadenocarcinoma', 'tissue_source_site': '31', 'form_completion_date': '2009-10-20', 'pathologic_T': '[Not Applicable]', 'pathologic_M': '[Not Applicable]', 'clinical_M': '[Not Applicable]', 'pathologic_N': '[Not Applicable]', 'system_version': 'None', 'pathologic_stage': '[Not Applicable]', 'clinical_stage': 'Stage IIIC', 'clinical_T': '[Not Applicable]', 'clinical_N': '[Not Applicable]', 'extranodal_involvement': '[Not Applicable]', 'postoperative_rx_tx': 'None', 'primary_therapy_outcome_success': 'None', 'lymph_node_examined_count': 'None', 'primary_lymph_node_presentation_assessment': 'None', 'initial_pathologic_diagnosis_method': 'Tumor resection', 'number_of_lymphnodes_positive_by_he': 'None', 'eastern_cancer_oncology_group': '1', 'anatomic_neoplasm_subdivision': 'Bilateral', 'residual_tumor': 'None', 'histological_type_other': 'None', 'init_pathology_dx_method_other': '[Not Applicable]', 'karnofsky_performance_score': 'None', 'neoplasm_histologic_grade': 'G3', 'height': 'None', 'weight': 'None', 'number_of_lymphnodes_positive_by_ihc': 'None', 'tobacco_smoking_history': 'None', 'number_pack_years_smoked': 'None', 'stopped_smoking_year': 'None', 'performance_status_scale_timing': 'Pre-Adjuvant Therapy', 'laterality': 'None', 'targeted_molecular_therapy': 'None', 'year_of_tobacco_smoking_onset': 'None', 'anatomic_neoplasm_subdivision_other': 'None', 'patient_death_reason': 'None', 'tumor_tissue_site_other': 'None', 'menopause_status': 'None', 'margin_status': 'None', 'kras_gene_analysis_performed': 'None', 'venous_invasion': 'NO', 'lymphatic_invasion': 'NO', 'perineural_invasion_present': 'None', 'her2_immunohistochemistry_level_result': 'None', 'breast_carcinoma_progesterone_receptor_status': 'None', 'breast_carcinoma_surgical_procedure_name': 'None', 'breast_neoplasm_other_surgical_procedure_descriptive_text': 'None', 'axillary_lymph_node_stage_method_type': 'None', 'breast_carcinoma_estrogen_receptor_status': 'None', 'cytokeratin_immunohistochemistry_staining_method_micrometastasi': 'None', 'lab_proc_her2_neu_immunohistochemistry_receptor_status': 'None', 'lab_procedure_her2_neu_in_situ_hybrid_outcome_type': 'None', 'additional_pharmaceutical_therapy': 'None', 'additional_radiation_therapy': 'None', 'lymphovascular_invasion_present': 'None', 'location_in_lung_parenchyma': 'None', 'pulmonary_function_test_performed': 'None', 'egfr_mutation_performed': 'None', 'diagnosis': 'None', 'eml4_alk_translocation_performed': 'None', 'days_to_new_tumor_event_after_initial_treatment': 'None', 'hemoglobin_result': 'None', 'serum_calcium_result': 'None', 'platelet_qualitative_result': 'None', 'number_of_lymphnodes_positive': 'None', 'white_cell_count_result': 'None', 'alcohol_history_documented': 'None', 'family_history_of_cancer': 'None', 'braf_gene_analysis_performed': 'None', 'city_of_procurement': 'None', 'surgical_approach': 'None', 'peritoneal_wash': 'None', 'total_pelv_lnr': 'None', 'total_aor_lnr': 'None', 'prior_glioma': 'None'}], 'var_function-call-3278334101924332887': [{'column_name': 'stopped_smoking_year'}, {'column_name': 'days_to_initial_pathologic_diagnosis'}, {'column_name': 'number_of_lymphnodes_positive_by_he'}, {'column_name': 'age_at_initial_pathologic_diagnosis'}, {'column_name': 'year_of_tobacco_smoking_onset'}, {'column_name': 'year_of_initial_pathologic_diagnosis'}, {'column_name': 'height'}, {'column_name': 'weight'}, {'column_name': 'number_of_lymphnodes_positive_by_ihc'}, {'column_name': 'days_to_birth'}, {'column_name': 'total_pelv_lnr'}, {'column_name': 'total_aor_lnr'}, {'column_name': 'number_pack_years_smoked'}, {'column_name': 'prior_dx'}, {'column_name': 'ethnicity'}, {'column_name': 'informed_consent_verified'}, {'column_name': 'person_neoplasm_cancer_status'}, {'column_name': 'patient_id'}, {'column_name': 'histological_type'}, {'column_name': 'tissue_source_site'}, {'column_name': 'form_completion_date'}, {'column_name': 'pathologic_T'}, {'column_name': 'pathologic_M'}, {'column_name': 'clinical_M'}, {'column_name': 'pathologic_N'}, {'column_name': 'system_version'}, {'column_name': 'pathologic_stage'}, {'column_name': 'clinical_stage'}, {'column_name': 'clinical_T'}, {'column_name': 'clinical_N'}, {'column_name': 'extranodal_involvement'}, {'column_name': 'postoperative_rx_tx'}, {'column_name': 'primary_therapy_outcome_success'}, {'column_name': 'lymph_node_examined_count'}, {'column_name': 'primary_lymph_node_presentation_assessment'}, {'column_name': 'initial_pathologic_diagnosis_method'}, {'column_name': 'eastern_cancer_oncology_group'}, {'column_name': 'anatomic_neoplasm_subdivision'}, {'column_name': 'residual_tumor'}, {'column_name': 'histological_type_other'}, {'column_name': 'init_pathology_dx_method_other'}, {'column_name': 'karnofsky_performance_score'}, {'column_name': 'neoplasm_histologic_grade'}, {'column_name': 'tobacco_smoking_history'}, {'column_name': 'performance_status_scale_timing'}, {'column_name': 'laterality'}, {'column_name': 'targeted_molecular_therapy'}, {'column_name': 'anatomic_neoplasm_subdivision_other'}, {'column_name': 'patient_death_reason'}, {'column_name': 'tumor_tissue_site_other'}, {'column_name': 'menopause_status'}, {'column_name': 'margin_status'}, {'column_name': 'kras_gene_analysis_performed'}, {'column_name': 'venous_invasion'}, {'column_name': 'lymphatic_invasion'}, {'column_name': 'perineural_invasion_present'}, {'column_name': 'her2_immunohistochemistry_level_result'}, {'column_name': 'breast_carcinoma_progesterone_receptor_status'}, {'column_name': 'breast_carcinoma_surgical_procedure_name'}, {'column_name': 'breast_neoplasm_other_surgical_procedure_descriptive_text'}, {'column_name': 'axillary_lymph_node_stage_method_type'}, {'column_name': 'breast_carcinoma_estrogen_receptor_status'}, {'column_name': 'cytokeratin_immunohistochemistry_staining_method_micrometastasi'}, {'column_name': 'lab_proc_her2_neu_immunohistochemistry_receptor_status'}, {'column_name': 'lab_procedure_her2_neu_in_situ_hybrid_outcome_type'}, {'column_name': 'additional_pharmaceutical_therapy'}, {'column_name': 'additional_radiation_therapy'}, {'column_name': 'lymphovascular_invasion_present'}, {'column_name': 'location_in_lung_parenchyma'}, {'column_name': 'pulmonary_function_test_performed'}, {'column_name': 'egfr_mutation_performed'}, {'column_name': 'diagnosis'}, {'column_name': 'eml4_alk_translocation_performed'}, {'column_name': 'days_to_new_tumor_event_after_initial_treatment'}, {'column_name': 'hemoglobin_result'}, {'column_name': 'serum_calcium_result'}, {'column_name': 'platelet_qualitative_result'}, {'column_name': 'number_of_lymphnodes_positive'}, {'column_name': 'white_cell_count_result'}, {'column_name': 'alcohol_history_documented'}, {'column_name': 'family_history_of_cancer'}, {'column_name': 'braf_gene_analysis_performed'}, {'column_name': 'city_of_procurement'}, {'column_name': 'surgical_approach'}, {'column_name': 'peritoneal_wash'}, {'column_name': 'Patient_description'}, {'column_name': 'prior_glioma'}, {'column_name': 'days_to_death'}, {'column_name': 'days_to_last_followup'}, {'column_name': 'icd_10'}, {'column_name': 'tissue_retrospective_collection_indicator'}, {'column_name': 'icd_o_3_histology'}, {'column_name': 'tissue_prospective_collection_indicator'}, {'column_name': 'history_of_neoadjuvant_treatment'}, {'column_name': 'icd_o_3_site'}, {'column_name': 'tumor_tissue_site'}, {'column_name': 'new_tumor_event_after_initial_treatment'}, {'column_name': 'radiation_therapy'}, {'column_name': 'race'}], 'var_function-call-15269997820402354601': [{'Patient_description': 'Clinical entry D13FB44B-291B-4EA4-920C-142DAA8D1989 identifies patient TCGA-AC-A5EH, a FEMALE subject with Breast invasive carcinoma. Their current vital status is Alive.', 'histological_type': 'Infiltrating Ductal Carcinoma'}, {'Patient_description': 'Record 09A5E9FD-D816-4F8C-BAA9-0E40BA607B16 refers to patient TCGA-LL-A7SZ, a FEMALE diagnosed with Breast invasive carcinoma. Vital status recorded as Alive.', 'histological_type': 'Infiltrating Ductal Carcinoma'}, {'Patient_description': "Patient TCGA-AN-A0FY, registered under UUID de75d0b9-0f47-4732-8df5-05c350cfcd32, belongs to the Breast invasive carcinoma cohort. This FEMALE patient's vital status is Alive.", 'histological_type': 'Infiltrating Ductal Carcinoma'}, {'Patient_description': 'Patient TCGA-AC-A2FB (UUID 02BBB632-0F7F-439D-B8F0-C86A06237424) is a FEMALE diagnosed with Breast invasive carcinoma. Current vital status: Alive.', 'histological_type': 'Infiltrating Lobular Carcinoma'}, {'Patient_description': 'The individual with barcode TCGA-AO-A1KR and UUID b7f74ae1-6f58-447c-be50-a7666eb19d9a is a FEMALE case of Breast invasive carcinoma, documented with vital status = Alive.', 'histological_type': 'Infiltrating Ductal Carcinoma'}], 'var_function-call-16812976707986845495': [{'Patient_description': "Patient TCGA-DK-A6AW, registered under UUID 01C815BA-7BDA-4F7E-865C-0C5776FEBF2C, belongs to the Bladder urothelial carcinoma cohort. This MALE patient's vital status is Alive.", 'histological_type': 'Muscle invasive urothelial carcinoma (pT2 or above)'}, {'Patient_description': 'In the Bladder urothelial carcinoma dataset, patient TCGA-GD-A3OQ (UUID 2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3) is recorded as a MALE with vital status: Alive.', 'histological_type': 'Muscle invasive urothelial carcinoma (pT2 or above)'}, {'Patient_description': 'The individual with barcode TCGA-CF-A47W and UUID 122FC134-8915-47DB-96C9-AB1853C3CD18 is a MALE case of Bladder urothelial carcinoma, documented with vital status = Alive.', 'histological_type': 'Muscle invasive urothelial carcinoma (pT2 or above)'}, {'Patient_description': 'Patient TCGA-CF-A3MF (MALE, UUID 1E308B12-0590-4DAE-94D0-A539FCF25DF7) is enrolled in the study of Bladder urothelial carcinoma. Vital status: Alive.', 'histological_type': 'Muscle invasive urothelial carcinoma (pT2 or above)'}, {'Patient_description': 'Case DE810AF0-4C18-4E8F-9836-F8ABC425E3EB, linked to barcode TCGA-DK-A2I6, corresponds to a MALE patient diagnosed with Bladder urothelial carcinoma, with vital status Alive.', 'histological_type': 'Muscle invasive urothelial carcinoma (pT2 or above)'}], 'var_function-call-4813916406073336699': 'file_storage/function-call-4813916406073336699.json', 'var_function-call-8760586505566200375': 'file_storage/function-call-8760586505566200375.json'}

exec(code, env_args)
